Carrie Printz. "PORTEC‐3 trial finds that adjuvant chemoradiotherapy significantly improves 10‐year survival for patients with high‐risk endometrial cancer." CA: A Cancer Journal for Clinicians, 2026. doi:10.3322/caac.70063